← Leaderboards
Rui Xiong
University Of Illinois At Chicago
$2,599,679
Attributed
$2,599,679
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $700.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,599,679 · 1
By mechanism
R01$2,599,679 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Andrew D Mesecar$12,210,126
- Deepak Shukla$19,733,938
- Abhijit A Date$4,064,660
- Arun K Ghosh$14,662,368
- Michael E. Johnson$23,655,611
Others in their field
Other Rising Stars on “Drug Candidate”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Jason Dickens · Duke University$12,259,409
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Research focus
Drug CandidateDrug Discovery2019-NcovDoseAffinityAntiviral Drug DevelopmentAnti-Viral EfficacyAnimal ModelActive SitesDistalBiochemicalBiological AvailabilityCaspaseCell ModelCellsComplementComplexCovid-19 PandemicCovid-19 TreatmentBindingBinding SitesCysteineDesignDrug Exposure
Grant awards (5)
Targeting SARS-CoV-2 PLpro for COVID-19 treatment$616,612
R01 · FY2025 · AI · contact PI
Targeting SARS-CoV-2 PLpro for COVID-19 treatment$700,291
R01 · FY2024 · AI · contact PI
Targeting SARS-CoV-2 PLpro for COVID-19 treatment$600,292
R01 · FY2023 · AI · contact PI
Targeting SARS-CoV-2 PLpro for COVID-19 treatment$641,337
R01 · FY2022 · AI · contact PI
Targeting SARS-CoV-2 PLpro for COVID-19 treatment$41,147
R01 · FY2022 · AI · contact PI